Predictors of response to ziprasidone: results from a 6-week randomized
double-blind, placebo-controlled trial for acute depressive mixed state.
Author(s): Pae CU, Patkar AA, Gilmer W, Holtzman N, Thommi SB, Ghaemi SN.
Affiliation(s): Department of Psychiatry, Duke University Medical Center, Durham, NC, USA.
Publication date & source: 2012, Pharmacopsychiatry. , 45(4):152-5
INTRODUCTION: The present study is aimed at investigating possible predictors of
response to ziprasidone in a sample of patients with mixed depressive state.
METHODS: 72 patients were randomized to either ziprasidone or placebo and treated
prospectively for 6 weeks. The clinical response and remission were defined with
various clinical variables including Montgomery Asberg Depression Rating Scale.
Further outcome measures included predictors of remission and other clinical
variables over time.
RESULTS: None of the variables under investigation were significantly associated
with response or remission at 6 weeks (all p-values>0.003, respectively).
CONCLUSIONS: Further investigations are warranted due to clear limitations,
mostly small sample size and use of concomitant medications.
|